References
- Blauwkamp TA, Thair S, Rosen MJ, Blair L, Lindner MS, Vilfan ID, Kawli T, Christians FC, Venkatasubrahmanyam S, Wall GD, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat Microbiol. 2019;4(4):663–74. doi:10.1038/s41564-018-0349-6.
- Farnaes L, Wilke J, Ryan Loker K, Bradley JS, Cannavino CR, Hong DK, Pong A, Foley J, Coufal NG. Community-acquired pneumonia in children: cell-free plasma sequencing for diagnosis and management. Diagn Microbiol Infect Dis. 2019; Jun94(2):188–91. doi:10.1016/j.diagmicrobio.2018.12.016.
- Dworsky ZD, Lee B, Ramchandar N, Rungvivatjarus T, Coufal NG, Bradley JS. Impact of cell-free next-generation sequencing on management of pediatric complicated pneumonia. Hosp Pediatr. 2022; Apr 112(4):377–84. doi:10.1542/hpeds.2021-006361.
- Wilke J, Ramchandar N, Cannavino C, Pong A, Tremoulet A, Padua LT, Harvey H, Foley J, Farnaes L, Coufal NG. Clinical application of cell-free next-generation sequencing for infectious diseases at a tertiary children’s hospital. BMC Infect Dis. 2021;21(1):552–7. doi:10.1186/s12879-021-06292-4.
- Armstrong AE, Rossoff J, Hollemon D, Hong DK, Muller WJ, Chaudhury S. Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease. Pediatr Blood Cancer. 2019; Jul66(7):e27734. e27734. doi:10.1002/pbc.27734.
- Goggin KP, Gonzalez-Pena V, Inaba Y, Allison KJ, Hong DK, Ahmed AA, Hollemon D, Natarajan S, Mahmud O, Kuenzinger W, et al. Evaluation of plasma microbial cell-free DNA sequencing to predict bloodstream infection in pediatric patients with relapsed or refractory cancer. JAMA Oncol. 2020;6(4):552–6. doi:10.1001/jamaoncol.2019.4120.
- Craver R, Collier S, Anderson M. Cell free microbial DNA utilization at a children’s hospital. Pediatr Devel Pathol. 2023;26(2):174–236.